openPR Logo
Press release

Hydrate Inhibitors Market Industry Insights and Growth 2025

04-16-2018 08:50 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Hydrate Inhibitors Market

North America is the largest market for hydrate inhibitors. This is primarily due to extreme high pressures and 40OF temperature in the Gulf of Mexico which is a large oil producing zone. Wells in Alaska also require the use of hydrate inhibitors. Kaikias deep-water in the Gulf of Mexico is currently in Appraisal Phase and will be commissioned by 2020.

Middle East and Africa is also showing a significant growth in hydrate inhibitors market due to the substantial number of hydrate threatened wells. Saudi Arabia controls the world’s largest offshore oil field and Qatar is the largest producer of LNG in the world. The largest gas field in the world is also present in this region.

Sample Copy of This Report@ https://www.coherentmarketinsights.com/insight/request-sample/555

Europe is the next largest market with conditions conducive to hydrate formation present in oil fields of North Sea and Russia. With increased exploration and drilling in the Arctic where sub-zero temperatures are the norm, hydrate inhibition shows vital performance which will drive the hydrate inhibitors market.

Asia Pacific market is expected to augment market growth in the near future, as exploration in the offshore regions of Bay of Bengal, South China Sea and Indian Ocean gains momentum. The emerging countries of this region such as India, China, Indonesia are highly dependent on oil imports from Middle East, ramped up exploration activity is due to a need to become energy independent. In June 2017, Reliance and BP sanctioned further development in KG Basin with an investment of US$ 6 billion.

Latin America is projected to witness an increase in hydrate inhibitor market as oil production moves to deep and ultra-deep-water zones due to depletion of onshore reserves. Exploiting the reserves of Santos basin off the coast of Brazil will require hydrate inhibition due to low temperatures on the Atlantic seabed. This will boost hydrate inhibitors market in the region. Chile and Argentina are expected to follow suit in exploiting offshore reserves.

The environmental concerns regarding methanol, which is a toxic chemical, have led to development of newer hydrate inhibition methods such as Low Dosage Hydrate Inhibitors and use of MEG instead of Methanol. This switch has had environmental, technical and economic perks. Major players in the hydrate inhibitor market are Ashland, Halliburton, NALCO (ECOLAB COMPANY), Woodview Technology, BASF, NEFTECHIM Technologies, JSC Gazprom Neftekhim Salavat, Clariant Chemicals, GasHydrate LLC, Evonik, Ecolab, ClariantOilServices, Yara International, Stella Mar, LEWA

Hydrate Inhibitors Market Taxonomy

On basis of Inhibitor Type

Thermodynamic Inhibitors,Methanol,Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s): Anti-Agglomeration Inhibitors/Surfactants, Quaternary Ammonium Compounds,Amides, Bio-surfactants

Kinetic Inhibitors: Polyvinylcaprolactam, Polyvinylpyrrolidone, Polyethyloxazoline, N-methyl-N-vinylacetamide, Tetra pentyl ammonium bromide, Butoxy-ethanol, Emulsifiers, Hybrid, Others

Thermodynamic inhibitors on addition shift the thermodynamic equilibrium and disrupting hydrate formation. Methanol and MEG are most commonly used. MEG can be regenerated and is more cost effective. Methanol though cheaper on volume basis cannot be regenerated and is not environment friendly as well.

To get detailed table of content (ToC)@ https://www.coherentmarketinsights.com/ongoing-insight/toc/555

Low Dosage Hydrate Inhibitors are used when large concentrations of thermodynamic inhibitors are required, making their use uneconomical. They do not disturb thermodynamic equilibrium, instead affect the hydrate growth. Anti-Agglomeration Agents prevent the agglomeration of hydrate crystals by disrupting hydrate growth process and transportable slurry is formed. These inhibitors are typically used below a 50% water cut level. Kinetic Inhibitors prevent nucleation, so the produced fluid is transported further to downstream before hydrate formation.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah

Coherent Market Insights
1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hydrate Inhibitors Market Industry Insights and Growth 2025 here

News-ID: 1017047 • Views:

More Releases from Hydrate Inhibitors Market

Hydrate Inhibitors Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025
Hydrate Inhibitors Market - Global Industry Insights, Trends, Outlook, and Oppor …
Hydrate Inhibitors are used to prevent or reduce gas hydrate formation. Gas Hydrates are formed in offshore production systems under low temperature and high pressure conditions. The hydrates block the pipelines, drill strings, BOP’s, by forming plugs and cause flow assurance issues. Hydrate inhibitors are used where mechanical methods such as insulated flow line and active heating are not feasible options. Subsea equipment such as pipelines, risers, Christmas trees, jumpers and

More Releases for Inhibitor

Immune Checkpoint Inhibitor
Immune Checkpoint Inhibitors Market Insights 2019, Global and Chinese Scenario is a professional and indepth study on the current state of the global Immune Checkpoint Inhibitors industry with a focus on the Chinese market. The report provides key statistics on the market status of the Immune Checkpoint Inhibitors manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an
Galectin Inhibitor Therapeutics - Pipeline Analysis 2019
Galectins belong to the family of animal lectins and perform function by interacting with cytoplasmic and nuclear proteins, cell-surface and extracellular matrix glycoproteins and glycolipids to modulate signalling pathways. Studies have shown the crucial roles of galectin in cancer as they contribute to tumour cell survival, tumour metastasis, angiogenesis and neoplastic transformation. Download the sample Report @ https://www.pharmaproff.com/request-sample/1209 Many studies have demonstrated role of galectins in the pathogenesis of various diseases including
Galectin Inhibitor Therapeutics - Pipeline Analysis 2019
Galectins belong to the family of animal lectins and perform function by interacting with cytoplasmic and nuclear proteins, cell-surface and extracellular matrix glycoproteins and glycolipids to modulate signalling pathways. Studies have shown the crucial roles of galectin in cancer as they contribute to tumour cell survival, tumour metastasis, angiogenesis and neoplastic transformation. Download the sample Report @ https://www.pharmaproff.com/request-sample/1209 Many studies have demonstrated role of galectins in the pathogenesis of various diseases including
Neuroendocrine Carcinoma Market: Both tyrosine kinase inhibitor and mTOR inhibit …
Recently, Future Market Insights has presented value analysis and insights on the various disease types, treatment types and end users associated with the neuroendocrine carcinoma market across key regions in the globe. It has also included an in-depth analysis on the various key players participating in the global neuroendocrine carcinoma market along with key developments taking place during the 2017-2027 timeline. Future Market Insights, in its recent publication titled “Neuroendocrine
Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor o …
"The Report Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Summary Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) pipeline Target constitutes close to 10 molecules. Out of which approximately 3 molecules are developed by companies and remaining by the universities/institutes. The latest report
Cytokine Inhibitor Market Research Report 2017
Reports And Markets Publish a New Market Research Report On –"Cytokine Inhibitor Market Research Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/global-cytokine-inhibitor-market-research-report-2017-1541209 In this report, the global Cytokine Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions,